nafazatrom has been researched along with Kidney Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambrus, CM; Ambrus, JL; Gastpar, H; Williams, P | 1 |
| Carreras, LO; Chamone, DA; van Damme, B; Vermylen, J | 1 |
2 other study(ies) available for nafazatrom and Kidney Neoplasms
| Article | Year |
|---|---|
Study of platelet aggregation in vivo. IX. Effect of nafazatrom on in vivo platelet aggregation and spontaneous tumor metastasis.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Carcinoma, Ehrlich Tumor; Female; Fibrinolytic Agents; Kidney Neoplasms; Lung Neoplasms; Macaca; Male; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Neoplastic Cells, Circulating; Neuroblastoma; Platelet Aggregation; Pyrazoles; Pyrazolones; Rats; Wilms Tumor | 1982 |
Increased release of vascular prostacyclin-like activity after long-term treatment of diabetic rats with Bay g 6575.
Topics: Adenoma; Animals; Aorta; Diabetes Mellitus, Experimental; Epoprostenol; Female; Fibrinolytic Agents; Kidney; Kidney Neoplasms; Male; Prostaglandins; Pyrazoles; Pyrazolones; Rats; Rats, Inbred Strains; Time Factors | 1981 |